Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 67

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 67
---
 of all other conditions set forth in the Merger Agreement (other than                                     
 those conditions that by their terms are to be satisfied at Closing) TuHURA is incapable of closing the Concurrent Investment before the End Date. |

Termination Fees (see page 252) Upon termination of the Merger Agreement (i) by Kineta to accept and enter into a definitive agreement with respect to a Superior Proposal; (ii) by TuHURA because the Kineta Board Directors has effected and Adverse Recommendation Change, failed to publicly reaffirm the Recommendation per the terms of the Merger Agreement or Kineta committed a willful and material breach of its non-solicitationcovenants; or (iii) (A) the Merger Agreement is terminated by either TuHURA or Kineta because the Mergers have not been effected before the End Date, there is a law enjoining the consummation of the Mergers, the Kineta Stockholder Approval has not been obtained or the TuHURA Stockholder Approval has not been obtained and (B) in the Pre-ClosingPeriod, an Acquisition Proposal was communicated to Kineta or to Kineta’s stockholders and, in either case, has not been publicly withdrawn and within twelve (12) months after such termination, Kineta enters into a definitive agreement that would have constituted an Acquisition Proposal (provided, that for these purposes, the references in the definition of “Acquisition Proposal” to “20% or more” are replaced by “more than 50%”), Kineta will be required to pay TuHURA a termination fee of $1,000,000; or (b) by Kineta, if TuHURA is unable to close the Concurrent Investment before the End Date and all other conditions to Closing are satisfied, TuHURA will be required to pay Kineta a termination fee of $1,000,000. Certain Agreements Related to the Mergers (see page 253) Exclusivity and Right of First Offer Agreement On July 3, 2024 (the “Exclusivity Agreement Effective Date”), Kineta and TuHURA entered into an exclusivity and right of first offer agreement (the “Exclusivity Agreement”), pursuant to which, among other things, Kineta granted TuHURA an exclusive right to acquire Kineta’s worldwide patents, patent rights, patent

39

applications, product and development program assets, technical and business information, and other rights and assets associated with and derived from its development program related to KVA